Trials / Unknown
UnknownNCT03668574
Effects of Aerobic Exercises in Patients With Low Back Pain
Aerobic Exercise for Patients With Non-specific Chronic Low Back Pain: a Feasibility Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Universidade Cidade de Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to test the feasibility of a clinical trial testing the effectiveness of aerobic exercises program in patients with chronic non-specific low back pain.
Detailed description
A total of 30 patients with chronic non-specific low back pain (with a duration of at least 12 weeks) who are seeking for treatment will be recruited. These patients will be randomly allocated into two groups. Patients allocated to the placebo group will be treated twice a week for a total of 12 weeks with detuned ultrasound and shortwave therapy Patients allocated to the exercise group will be trained with aerobic exercises on a treadmill twice a week for a total of 12 weeks. Primary outcomes will be pain and disability. Feasibility outcomes will be adherence, satisfaction and recruitment. Kinesiophobia, perceived global effect and physical capacity will also be analyzed as secondary outcomes. The outcome assessor of this trial will be blinded to the group allocation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aerobic exercise | Aerobic exercise that is defined as a form of exercise lasting 15 to 60 minutes continuous and intensity of 60% to 90% of maximal heart rate. |
| OTHER | Placebo Group | Will be treated with pulsed 5-minute ultrasound and pulsed short-wave diathermy for 25 minutes. The devices will be used with disconnected internal cables to obtain the placebo effect |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-11-15
- Completion
- 2019-12-30
- First posted
- 2018-09-12
- Last updated
- 2019-09-25
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03668574. Inclusion in this directory is not an endorsement.